Gujarat Ambuja Exports Ltd
Gujarat Ambuja Exports Ltd
FMCGKey Fundamentals
MicrocapAgricultural ProductsFMCGInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Gujarat Ambuja Exports Ltd insights
29 extracted metrics + investor summaries across FY12–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
3- The company has delivered a poor sales growth of 4.01% over past five years.
- Company has a low return on equity of 10.4% over last 3 years.
- Dividend payout has been low at 3.06% of profits over last 3 years
Growth Rate
AI Analysis — Bull vs Bear
Gujarat Ambuja Exports Ltd is an agro-processing and maize starch derivatives company with a market cap of ₹8,046 Cr, trading at a PE of 26x. FY25 standalone revenue declined to ₹4,696 Cr from ₹5,071 Cr in FY24, and net profit fell to ₹251 Cr from ₹346 Cr, reflecting margin pressure from commodity volatility and weak export demand in its maize segment.
- Strong long-term stock CAGR of 24% over 10 years, indicating sustained wealth creation for long-term holders
- TTM sales growth of 24% and TTM profit growth of 24% suggest a recent recovery in operational momentum
- Low debt-to-equity ratio of 0.13x with a current ratio of 3.19, indicating a strong balance sheet and comfortable liquidity
- Healthy interest coverage ratio of ~21x, reflecting minimal financial stress from debt servicing (finance costs only ₹17 Cr on ₹4,696 Cr revenue)
- Dominant market position in Indian maize processing segment with diversified product portfolio (starch, liquid glucose, dextrose syrup, high maltose corn syrup, soya derivatives, cotton yarn)
- Stock price appreciated 57% over the last 1 year, reflecting renewed investor confidence
- 10-year compounded profit growth of 12% shows ability to grow earnings over full business cycles despite interim volatility
- FY25 standalone net profit declined 28% YoY to ₹251 Cr from ₹346 Cr in FY24, indicating significant earnings deterioration
- Poor 5-year compounded sales growth of just 4%, well below inflation, reflecting structural growth challenges
- Low 3-year ROE of only 10.4%, suggesting sub-optimal capital efficiency for shareholders
- Dividend payout of just 3.06% of profits over last 3 years with a yield of only 0.14%, offering negligible income to shareholders
- FY25 revenue fell 7.4% YoY to ₹4,696 Cr from ₹5,071 Cr, with CARE Ratings citing decline in export demand and domestic oversupply in maize processing
- 3-year compounded profit growth is negative at -2%, indicating earnings have stagnated over a medium-term horizon
- Operating margins vulnerable to agro-commodity price volatility and foreign exchange fluctuations as flagged by credit rating agencies
- PE of 26x appears elevated relative to the company's modest 5-year profit CAGR of -2%, implying limited margin of safety at current valuation
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Net profit surges 171% YoY Aug 1
Standalone net profit jumped 171% YoY to ₹176.93 crore in Q1FY27, signaling strong operational performance across divisions.
- Revenue grows 23.5% YoY Aug 1
Q1FY27 revenue rose 23.5% to ₹1,594.27 crore, driven primarily by the Maize Processing Division.
- Maize segment profits spike Aug 1
Maize Processing Division segment profits jumped to ₹190.41 crore in Q1FY27, indicating strong margin expansion in the core business.
- Q1 results approved by board Aug 1
Board approved Q1FY27 results on August 1, 2026, following review by auditors Kantilal Patel & Co. Routine corporate governance disclosure.
TL;DR: GAEL delivered a standout Q1FY27 with 171% profit growth and 23.5% revenue expansion, led by a dominant Maize Processing Division. No visible headwinds emerged from this reporting cycle. The trend is clearly improving, with strong margin expansion suggesting operational leverage is kicking in. Sustainability of maize segment margins into subsequent quarters will be the key monitorable.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,163 | 1,116 | 1,302 | 1,346 | 1,090 | 1,125 | 1,131 | 1,267 | 1,291 | 1,487 | 1,484 | 1,467 | 1,594 |
| Expenses | 1,061 | 1,012 | 1,176 | 1,235 | 985 | 1,015 | 1,008 | 1,204 | 1,195 | 1,411 | 1,385 | 1,272 | 1,362 |
| Operating Profit | 102 | 103 | 126 | 111 | 106 | 110 | 123 | 62 | 96 | 76 | 99 | 195 | 232 |
| OPM % | 9% | 9% | 10% | 8% | 10% | 10% | 11% | 4.9% | 7% | 5% | 7% | 13% | 15% |
| Other Income | 27 | 42 | 39 | 37 | 29 | 20 | 9 | 25 | 30 | 19 | 28 | 26 | 39 |
| Interest | 6 | 6 | 3 | 3 | 3 | 4 | 3 | 6 | 5 | 9 | 6 | 7 | 2 |
| Depreciation | 30 | 30 | 30 | 30 | 31 | 31 | 32 | 32 | 35 | 35 | 33 | 34 | 33 |
| PBT | 92 | 109 | 131 | 115 | 100 | 94 | 97 | 49 | 86 | 51 | 88 | 180 | 235 |
| Tax % | 23% | 24% | 23% | 21% | 24% | 26% | 27% | 35% | 24% | 25% | 25% | 25% | 25% |
| Net Profit | 71 | 83 | 101 | 91 | 77 | 69 | 71 | 32 | 65 | 38 | 66 | 135 | 177 |
| EPS in Rs | 1.55 | 1.8 | 2.2 | 1.99 | 1.67 | 1.51 | 1.56 | 0.7 | 1.42 | 0.83 | 1.44 | 2.95 | 3.85 |
Profit & Loss
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,122 | 3,016 | 3,092 | 2,531 | 2,736 | 3,817 | 4,705 | 4,670 | 4,909 | 4,927 | 4,613 | 5,729 | 6,032 |
| Expenses | 2,016 | 2,821 | 2,897 | 2,367 | 2,549 | 3,527 | 4,171 | 3,983 | 4,433 | 4,484 | 4,211 | 5,261 | 5,429 |
| Operating Profit | 106 | 194 | 195 | 165 | 188 | 289 | 535 | 687 | 476 | 443 | 401 | 468 | 602 |
| OPM % | 5% | 6% | 6% | 6% | 7% | 8% | 11% | 15% | 10% | 9% | 9% | 8% | 10% |
| Other Income | 5 | 9 | 10 | 9 | 10 | 2 | 27 | 54 | 73 | 144 | 82 | 102 | 112 |
| Interest | 21 | 22 | 21 | 15 | 10 | 9 | 6 | 6 | 13 | 18 | 17 | 28 | 24 |
| Depreciation | 30 | 37 | 47 | 61 | 65 | 101 | 103 | 97 | 95 | 121 | 126 | 138 | 136 |
| PBT | 61 | 145 | 137 | 98 | 123 | 181 | 452 | 638 | 441 | 448 | 341 | 404 | 554 |
| Tax % | 18% | 22% | 19% | 14% | 16% | 20% | 25% | 26% | 25% | 23% | 27% | 25% | — |
| Net Profit | 50 | 113 | 111 | 84 | 104 | 146 | 338 | 475 | 330 | 346 | 249 | 304 | 416 |
| EPS in Rs | 0.9 | 2.04 | 2.01 | 1.52 | 1.87 | 3.18 | 7.37 | 10.36 | 7.2 | 7.54 | 5.44 | 6.63 | 9.07 |
| Div. Payout % | 17% | 10% | 9% | 14% | 11% | 8% | 4% | 3% | 5% | 0% | 5% | 5% | — |
Balance Sheet
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 28 | 28 | 28 | 28 | 23 | 23 | 23 | 23 | 46 | 46 | 46 |
| Reserves | 528 | 628 | 729 | 800 | 889 | 1,304 | 1,634 | 2,095 | 2,411 | 2,723 | 2,956 | 3,249 |
| Borrowings | 361 | 183 | 401 | 309 | 329 | 160 | 163 | 281 | 229 | 199 | 229 | 441 |
| Other Liabilities | 223 | 364 | 154 | 148 | 176 | 250 | 342 | 354 | 289 | 342 | 356 | 424 |
| Total Liabilities | 1,140 | 1,203 | 1,312 | 1,284 | 1,421 | 1,736 | 2,162 | 2,753 | 2,952 | 3,310 | 3,587 | 4,160 |
| Fixed Assets | 289 | 458 | 479 | 543 | 562 | 787 | 731 | 771 | 1,042 | 1,037 | 1,179 | 1,185 |
| CWIP | 169 | 38 | 64 | 63 | 101 | 12 | 106 | 246 | 87 | 153 | 235 | 443 |
| Investments | 44 | 44 | 42 | 52 | 73 | 22 | 180 | 714 | 650 | 840 | 938 | 1,061 |
| Other Assets | 638 | 662 | 727 | 626 | 686 | 915 | 1,146 | 1,022 | 1,172 | 1,280 | 1,234 | 1,472 |
| Total Assets | 1,140 | 1,203 | 1,312 | 1,284 | 1,421 | 1,736 | 2,162 | 2,753 | 2,952 | 3,310 | 3,587 | 4,160 |
Cash Flow
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -4 | 294 | -120 | 253 | 135 | 241 | 298 | 596 | 241 | 213 | 341 | 228 |
| Investing | -95 | -79 | -73 | -130 | -130 | -60 | -302 | -777 | -72 | -253 | -336 | -401 |
| Financing | 96 | -209 | 187 | -124 | -3 | -97 | 1 | 100 | -76 | -55 | -13 | 176 |
| Net Cash Flow | -2 | 6 | -6 | 0 | 2 | 84 | -3 | -81 | 93 | -95 | -8 | 4 |
| Free Cash Flow | -130 | 208 | -223 | 130 | 18 | 156 | 149 | 312 | 44 | 4 | 47 | -153 |
| CFO/OP | 18 | 165 | -45 | 165 | 82 | 96 | 78 | 111 | 72 | 68 | 107 | 69 |
Ratios
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 30 | 13 | 18 | 16 | 23 | 15 | 17 | 18 | 21 | 24 | 28 | 28 |
| Inventory Days | 79 | 67 | 75 | 82 | 73 | 74 | 77 | 76 | 69 | 81 | 79 | 70 |
| Days Payable | 29 | 40 | 10 | 12 | 14 | 17 | 18 | 21 | 15 | 18 | 14 | 13 |
| Cash Conversion Cycle | 79 | 41 | 83 | 86 | 82 | 72 | 76 | 73 | 75 | 87 | 94 | 84 |
| Working Capital Days | 10 | 14 | 21 | 30 | 29 | 42 | 44 | 31 | 44 | 56 | 56 | 42 |
| ROCE % | 10% | 19% | 15% | 9% | 11% | — | 28% | 30% | 18% | 16% | 11% | 12% |
Documents
Frequently Asked Questions about Gujarat Ambuja Exports Ltd
What does Gujarat Ambuja Exports Ltd do?
Where is Gujarat Ambuja Exports Ltd (GAEL) listed?
Which sector does Gujarat Ambuja Exports Ltd belong to?
What is the market capitalisation of Gujarat Ambuja Exports Ltd?
What is the PE ratio of Gujarat Ambuja Exports Ltd?
What is the 52-week high and low of Gujarat Ambuja Exports Ltd?
Does Gujarat Ambuja Exports Ltd pay dividends?
What is the Return on Equity (ROE) of Gujarat Ambuja Exports Ltd?
How can I research Gujarat Ambuja Exports Ltd on Tapetide?
Company Information
Gujarat Ambuja Exports is engaged in the manufacturing of Corn Starch Derivatives, Soya Derivatives, Feed Ingredients, Cotton Yarn, and Edible Oils. Since its incorporation in 1991, GAEL strives to serve the Food, Pharmaceutical, Feed, and many other industries with a long-term growth strategy in the Agro-Processing sector. (Source: Company Website)